| Immune checkpoint inhibitors and the risk of allograft rejection: a comprehensive analysis on an emerging issue LE Aguirre, ME Guzman, G Lopes, J Hurley The oncologist 24 (3), 394-401, 2019 | 60 | 2019 |
| Clival chondroid chordoma: a case report and review of the literature IS Erazo, CF Galvis, LE Aguirre, R Iglesias, LC Abarca, L Abarca Cureus 10 (9), 2018 | 23 | 2018 |
| Hypogammaglobulinemia and its implications in patients treated with daratumumab: a single institution experience Y Paul, LE Aguirre, F Basher, F Miao, T Koru-Sengul, JE Hoffman Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 15 | 2019 |
| Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes LE Aguirre, N Al Ali, DA Sallman, S Ball, AG Jain, O Chan, ... Leukemia, 1-10, 2023 | 14 | 2023 |
| Spontaneous remission of acute myeloid leukemia with NF1 alteration T Bradley, RA Zuquello, LE Aguirre, N Mackrides, J Chapman, L Cimmino, ... Leukemia Research Reports 13, 100204, 2020 | 11 | 2020 |
| A Product of Clash of Titans or True Reflection of Disease Biology? Validation of 2022 WHO and ICC Classifications in a Large Dataset of Patients with Myelodysplastic Syndrome S Ball, AM Singh, NA Ali, LE Aguirre, AG Jain, ZI Schwabkey, ... Blood 140 (Supplement 1), 1118-1120, 2022 | 8 | 2022 |
| It is time to shift the treatment paradigm in myelodysplastic syndromes: A focus on novel developments and current investigational approaches exploring combinatorial therapy in … LE Aguirre, R Komrokji, E Padron Best Practice & Research Clinical Haematology 34 (4), 101325, 2021 | 8 | 2021 |
| Aplasia in chronic phase CML post-TKI therapy: a management dilemma JL Ramdial, LE Aguirre, RA Ali, R Swords, M Goodman Case reports in hematology 2019, 2019 | 7 | 2019 |
| Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma JL Ramdial, LE Aguirre, RA Ali, R Swords, M Goodman Case reports in hematology 2019, 2019 | 7 | 2019 |
| Metastatic involvement of skeletal muscle from gastric adenocarcinoma LE Aguirre, J Salcedo, R Zuquello, M Garcia-Buitrago, B Ardalan Oxford medical case reports 2019 (8), omz081, 2019 | 6 | 2019 |
| Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes LEE Aguirre, AG Jain, S Ball, N Al Ali, SM Tinsley-Vance, DA Sallman, ... Blood 138 (Supplement 1), 1494-1494, 2021 | 5 | 2021 |
| The Natural History of Lower Risk MDS: Factors Predicting Progression to High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia in Patients with Very Low and Low Risk … AG Jain, S Ball, LE Aguirre, N Al Ali, D Kaldas, S Tinsley-Vance, ... Blood 138 (Supplement 1), 2600-2600, 2021 | 5 | 2021 |
| Characterization of TP53-Mutated Myelodysplastic Syndromes and Impact of Allelic Status and Concurrent Cytogenetic Abnormalities on Survival Outcomes LE Aguirre, N Al Ali, AG Jain, O Chan, S Ball, A Kuykendall, K Sweet, ... Blood 140 (Supplement 1), 4034-4035, 2022 | 4 | 2022 |
| Validation of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model for Myelodysplastic Syndromes LE Aguirre, N Al Ali, S Ball, AM Singh, AG Jain, O Chan, ZI Schwabkey, ... Blood 140 (Supplement 1), 1125-1127, 2022 | 4 | 2022 |
| U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes R Komrokji, LE Aguirre, N Al-Ali, M Hussaini, D Sallman, D Rollison, ... Blood Advances, 2022 | 4 | 2022 |
| Investigate the efficacy of immunotherapy for treatment of pancreatic adenocarcinoma (PDAC) with mismatch repair deficiency (dMMR). A Noor, LE Aguirre, K Blue, T Avriett, EM Carballido, RD Kim, DW Kim Journal of Clinical Oncology 39 (3_suppl), 415-415, 2021 | 4 | 2021 |
| Perspectivas en el abordaje farmacológico de la Epilepsia: una revisión extensa de la farmacoterapia LE Aguirre, D Leon-Benedetti Revista Ecuatoriana de Neurología 28 (3), 59-67, 2019 | 4 | 2019 |
| Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients A Torres, JL Ramdial, LE Aguirre, R Mahtani, CL Vogel Breast cancer research and treatment 176 (2), 253-260, 2019 | 4 | 2019 |
| Kaposiform Hemangioendothelioma of the GI Tract: An Exception to Occam’s Principle in an Adult with SBO LE Aguirre, RA Ali, DA Kerr, M Khanlari, G Lopes Case reports in oncological medicine 2019, 2019 | 4 | 2019 |
| Adult Langerhans cell histiocytosis presenting with multisystem involvement and sarcomatoid features: a case report LE Aguirre, I Schwartz, J Chapman, MF Larsen, A Alencar Journal of medical case reports 14 (1), 1-10, 2020 | 3 | 2020 |
Gilberto LopesSylvester Comprehensive Cancer Center at the University of MiamiVerified email at med.miami.edu
